Statements (40)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antihistamine
|
| gptkbp:approves |
gptkb:European_Union
gptkb:United_States |
| gptkbp:availableFormats |
preservative-free formulation
with preservatives |
| gptkbp:chemicalFormula |
C19H22ClN3O3S
|
| gptkbp:clinicalTrials |
Phase II
short-term treatment Phase III Phase I |
| gptkbp:contraindication |
hypersensitivity to the drug
|
| gptkbp:developedBy |
gptkb:Bausch_+_Lomb
|
| gptkbp:drugInterdiction |
available online
none significant peak plasma concentration in 1-2 hours rapid absorption ophthalmic antihistamines |
| gptkbp:expirationDate |
2 years
|
| gptkbp:formulation |
0.7% solution
|
| gptkbp:healthcare |
available online
|
| https://www.w3.org/2000/01/rdf-schema#label |
bepotastine besilate
|
| gptkbp:isATypeOf |
148553-50-8
|
| gptkbp:isRecognizedFor |
pregnant women
nursing mothers children under 2 years |
| gptkbp:issuedBy |
eye drops
|
| gptkbp:lastProduced |
2009
|
| gptkbp:marketedAs |
gptkb:Bepreve
|
| gptkbp:numberOfStudents |
3-4 hours
|
| gptkbp:operates_in |
S01GX08
|
| gptkbp:packaging |
bottle with dropper
|
| gptkbp:route |
topical
|
| gptkbp:safetyFeatures |
available online
|
| gptkbp:sideEffect |
headache
dry eyes taste disturbance burning sensation in the eyes |
| gptkbp:storage |
room temperature
|
| gptkbp:triggerType |
H1 receptor antagonist
|
| gptkbp:usedFor |
allergic conjunctivitis
|